1 What should I know about storage, disposal and expiration of compounded GLP-1 injections
Among the frontrunners are Semaglutide and Tirzepatide, both widely recognized for their proven efficacy
(Oral semaglutide is also newly approved and available.) Both of these medications reduce appetite and slow digestion, allowing you to eat fewer calories and feel full, resulting in weight loss when theyre paired with healthy habits like a balanced diet and exercise
Mean estimated treatment difference (ETD) values with associated 95% confidence intervals (CIs) were reported
IU = insulin units on a U-100 syringe
Durability of Results: Maintenance Studies: Tirzepatide (SURMOUNT-3): Continued treatment: Additional 5.5% weight loss Stopped treatment: Regained 14% of weight Conclusion: Need ongoing treatment Semaglutide (STEP-4): Continued treatment: Maintained loss, continued losing Stopped treatment: Regained most weight Conclusion: Need ongoing treatment Phentermine: FDA-approved for 12 weeks only Weight regain after stopping is universal Not a long-term solution All Weight Loss Medications: Obesity is chronic disease Medications treat symptoms, dont cure Stopping medication weight regain Long-term or indefinite use necessary for sustained results Safety Profile Comparison: Discontinuation Due to Side Effects: Tirzepatide: 6.2% Semaglutide: 6.9% Liraglutide: 9.9% Naltrexone-bupropion: 25% (very high) Orlistat: 15-20% Phentermine-topiramate: 8-10% GLP-1s have excellent tolerability considering their effectiveness